+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Personality Disorder Drug"

Borderline Personality Disorders - Epidemiology Forecast - 2032 - Product Thumbnail Image

Borderline Personality Disorders - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Borderline Personality Disorders - Pipeline Insight, 2024 - Product Thumbnail Image

Borderline Personality Disorders - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
  • 2 Results (Page 1 of 1)
Loading Indicator

The Personality Disorder Drug market is a subset of the Mental Disorders Drugs market, focusing on drugs used to treat personality disorders. These drugs are typically used to treat symptoms such as impulsivity, aggression, and difficulty with interpersonal relationships. Commonly prescribed drugs include antipsychotics, antidepressants, and mood stabilizers. These drugs are often used in combination with psychotherapy to help patients manage their symptoms. The Personality Disorder Drug market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, Eli Lilly, Johnson & Johnson, GlaxoSmithKline, and AstraZeneca. Other companies such as Novartis, Merck, and AbbVie also offer drugs for the treatment of personality disorders. Show Less Read more